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ABSTRACT
Recent technological advances have enabled us
to visualize the organization and dynamics of
local chromatin structures; however, the compre-
hensive mechanisms by which chromatin organiza-
tion modulates gene regulation are poorly
understood. We designed a human artificial chro-
mosome vector that allowed manipulation of trans-
genes using a method for delivering chromatin
architectures into different cell lines from human
to fish. This methodology enabled analysis of de
novo construction, epigenetic maintenance and
changes in the chromatin architecture of specific
genes. Expressive and repressive architectures of
human STAT3 were established from naked DNA in
mouse embryonic stem cells and CHO cells, respec-
tively. Delivery of STAT3 within repressive architec-
ture to embryonic stem cells resulted in STAT3
activation, accompanied by changes in DNA methy-
lation. This technology for manipulating a single
gene with a specific chromatin architecture could
be utilized in applied biology, including stem cell
science and regeneration medicine.
INTRODUCTION
Our ability to analyze human gene regulation and func-
tion has been advanced by the complete sequencing of
the genome and our increased knowledge of the interac-
tions between regulatory proteins and DNA elements.
However, our ability to analyze chromatin dynamics and
epigenetic regulation, including DNA methylation and
histone modiﬁcation, is limited, hindering our understand-
ing of the comprehensive mechanisms of gene regulation.
In particular, analyses using transgene have often been
dependent on transient expression of exogenous genes
and silenced or ectopic expression of integrated genes.
Novel technologies that allow direct analysis of native
gene expression based on chromatin structure are needed.
Chromosome technologies that utilize large-sized DNA
packaged into chromatin structures have been developed.
The main techniques involve the construction of chromo-
some fragments from human native chromosomes or
human artiﬁcial chromosomes (HACs) from naked
DNA (1–3) and the introduction of chromosomes using
microcell-mediated chromosome transfer (MMCT) (4).
HACs can be reproducibly generated de novo in human
HT1080 cells by transfection of long alpha-satellite DNA
containing CENP-B boxes (5–7). During their generation,
alphoid precursors are built up to mega-base size (2).
Previous studies have shown that chromosome fragments
and HACs replicate and segregate once per cell division
cycle to be stably maintained in mice (8,9), and can carry
large human genes that contain native regulatory regions
into human and animal cells (8–14). HACs provide several
potential advantages over viral and integrating vectors for
evaluating gene expression, including long-term stability,
low toxicity and huge size of inducible DNA.
Here, we designed and constructed a chromosome
vector that contained elements essential for chromosome
maintenance and a platform suitable for gene expression.
To assess the use of chromosome vectors as tools for ana-
lyzing gene regulation, we examined the construction,
maintenance and epigenetic changes of the chromatin
architecture using human STAT3 on the chromosome
vector as a model.
MATERIALS AND METHODS
Celllines
HT1080 cells were cultured in DMEM (Sigma) supple-
mented with 10% fetal bovine serum (FBS) at 378C and
5% CO2. CHO cells were cultured in Ham’s F-12 nutrient
mixture (Sigma) supplemented with 10% FBS at 378C and
5% CO2. TT2F mouse embryonic stem (ES) cells were
cultured in DMEM supplemented with 20% Knockout
SR (Invitrogen), 1000U/ml ESGRO (Chemicon) and
0.1mM b-mercaptoethanol. NIH/3T3 cells were cultured
in DMEM supplemented with 10% calf serum (CS). PK15
cells were cultured in MEM (Sigma) supplemented with
5% CS at 378C and 5% CO2. DT40 cells were cultured in
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chick serum and 0.05mM b-mercaptoethanol at 378C
and 5% CO2. A6 cells were cultured in DMEM (Sigma)
supplemented with 10% FBS at 268C and 5% CO2. AB.9
cells were cultured in DMEM (Sigma) supplemented with
15% FBS at 288C and 10% CO2. Cell lines harboring a
chromosome vector were selected with G418 (Sigma) at
300mg/ml (TT2F), 400mg/ml (HT1080, CHO), 600mg/ml
(NIH/3T3), 750mg/ml (PK15), 1000mg/ml (DT40),
1400mg/ml (AB.9) or 2000mg/ml (A6).
Aprecursor of the HAC vector,lox-BAC
Human beta-globin 50 hyper sensitive (50HS5) site (3.4-kb
EcoRI fragment; 4818-8173 in GenBank NG000007) was
cloned into the EcoRI site of pUC119, and 30 hyper sen-
sitive (30HS1) site (5.6-kb SphI-SacI fragment; 8255-13891
in GenBank AC104389) was cloned into the SphI-SacI
site of pTWV229 (TaKaRa) vector from YAC clone
A201F4.3. CAG promoter/lox71/neo cassette (CAG-
lox71-neo) was constructed from pCAGGS-bsr (15) by
deletion of the HindIII-HindIII fragment containing bsr
and insertion of neo from the PstI partial fragment of
SV-neo and I-SceI recognition site. Then, 50HS5, 30HS1
and CAG-lox71-neo were inserted into HpaI-SphI, SalI
and NotI sites of pBelo-BAC11 (New England BioLabs)
by blunt-end ligation to construct lox-BAC that contains
50HS5, CAG/lox71/neo and 30HS1, in that order.
Aprecursor of the HAC vector,alphoid-BAC
A pBelo-BAC vector was modiﬁed by insertion of the
kanamycin resistance gene in the BsmI-BsmI site, the
ampicillin resistance gene in SexAI-AhdI and the MluI/
SacII linker in the SalI-SalI site, followed by deletion of
the loxP site (BAC-AK). Finally, 50-kb alphoid fragment
was inserted into the MluI-SacI site of BAC-AK to con-
struct alphoid-BAC.
Donor plasmid
The plox66-puro was constructed from a 1.2-kb HindIII-
SalI fragment of pGK-puro (coding region of puro) and
a 3.0-kb HindIII-XhoI fragment of lox66-Nlaczeo (15)
(lox66). A 1.2-kb SpeI-KpnI fragment of plox66-puro
(lox66-puro cassette) was blunt-ended and inserted into
the HindIII site of pTWV229 (TWV-lox66-puro). The
CMV promoter in pEGFP-C1 was replaced with the SV,
EF1 and cyclin A promoters to construct SV-EGFP,
EF1-EGFP and cyclin A-GFP. The cyclin A promoter
was ampliﬁed by PCR from HT1080 genomic DNA pro-
moters. AseI-MluI fragments of pEGFP-C1 (CMV-
EGFP), SV-EGFP, EF1-EGFP and cyclin A-EGFP
were inserted into the SalI site of TWV(lox66)puro by
blunt-end ligation.
DNA transfection
To generate chromosome vectors, 1.0mg of alphoid-BAC
and 0.5mg of lox-BAC were co-transfected into HT1080
cells (5 10
5) using lipofectamine2000 (Invitrogen)
according to the manufacturer’s instructions.
Red-ET recombination
Red-ET recombination in Escherichia coli was performed
according to the manufacturer’s instructions (Gene
Bridges). To modify the loxP site in BAC clones with
the lox66/puro cassette, a linear fragment with homolo-
gous arms was prepared. The 200-bp arms homologous to
two sites of the BAC vector (Belo-BAC [6915-7114] and
Belo-BAC [51-250]) were inserted into the HindIII site and
EcoRI site in pTWV(lox66)puro to construct a circular
vector. Then, the target linear fragments were prepared
by digestion of the circular vector with HpaI and FspI,
and puriﬁcation of lox66/puro cassette with homologous
arms.
Microcell-mediated chromosome transfer
Forty 10-cm dishes of HT-A9/25-4 cells were grown to
80% conﬂuency and then cultured for 72h in DMEM
containing colcemid (0.05mg/ml). Collected cells were
incubated for 5min at 378C in serum-free DMEM con-
taining cytochalasin B (20mg/ml), then added to an equal
volume of Percoll (GE Healthcare). The suspension was
centrifuged in a Hitachi R20A2 rotor at 15000r.p.m. for
90min at 378C. The collected microcells were suspended in
serum-free DMEM, then mixed with recipient cells and
centrifuged at 2000r.p.m. for 5min. The resulting pellet
was ﬁnally suspended in 1ml 50% PEG1500 (Roche) and
incubated at room temperature for 90s. Five milliliters of
serum-free DMEM was added and the mixture was cen-
trifugated at 1000r.p.m. for 5min. The fused cells were
washed twice in serum-free DMEM and were plated.
Pulsed-field gel electrophoresis
DNA in agarose blocks was digested for 4h and size sepa-
rated in a 1% GTG agarose gel (Cambrex) on the CHEF
mapper system (Bio-Rad). The running conditions were
dependent on the auto algorithm from 5 to 500kb.
Southern analyses
DNA in the gel was transferred to a nylon membrane and
hybridized with
32P-labeled DNA probes prepared from
Belo-BAC vector DNA for detection of chromosome vec-
tors or a DNA probe from the 1234-bp fragment (MscI-
DraI) of the 50 region and 1283-bp fragment (AﬂII-MscI)
of the 30 region of human STAT3 gene for detecting
methylation status.
RT–PCR
Total RNA was prepared using SV Total RNA Isolation
System (Promega). Fifty nanograms of RNA were used
for RT–PCR using the One Step RNA PCR Kit (AMV)
(TaKaRa). For the full length human STAT3 gene (exons
2–24), the primers were hSTAT3F1: 50-TCAGCTCTACA
GTGACAGCTTCCCA-30 and hSTAT3R1: 50-GAGGTA
GCGCACTCCGAGGTCAAC-30. Samples were ampli-
ﬁed at 508C for 30min, 948C for 2min, 30 cycles at
948C for 15s, 688C for 15s and 728C for 2min. For full
length of mouse STAT3 gene (exons 2–24), the primers
were mSTAT3F1: 50-CCAGCTGTACAGCGACACGTT
CCCC-30 and mSTAT3R1: 50-GAGGTAGCACACTCC
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30min, 948C for 2min, 30 cycles at 948C for 15s, 658C
for 15s and 728C for 2min. To amplify human STAT3
exons 2–9, the primers were hSTAT3F1 and STATex9R:
50-TTCATTAAGTTTCTAAACAGCTCC-30. Samples
were ampliﬁed at 508C for 30min, 948C for 2min, 30
cycles at 948C for 15s, 618C for 15s and 728C for 1min.
Fluorescence in situ hybridization
Metaphase chromosomes were prepared on glass slides
after methanol/acetate (3:1) ﬁxation. Fluorescence in situ
hybridization (FISH) was performed using pBelo-BAC
DNA and 11-4 alphoid DNA as probes for detecting
HAC vectors according to a standard procedure.
Digoxigenin-labeled pBelo-BAC was visualized with
TRITC-conjugated anti-digoxigenin (Roche Diagnostics),
and Biotin-labeled 11-4 alphoid DNA (16) was visualized
with Alexa488-conjugated streptavidin (Invitrogen).
Photographs were taken using a CCD camera mounted
on a Zeiss microscope AxioPlan2. Images were processed
using AxioVision.
Indirect immunofluorescence
Indirect immunoﬂuorescence was performed using an
anti-human STAT3 antibody (Epitomics) which does not
cross-react with mouse Stat3. Mouse ES cells prepared on
glass slides using cytospin (Shandon) were ﬁxed in 2%
paraformaldehyde for 30min, reacted with an anti-
human STAT3 antibody, then visualized with FITC-
conjugated anti-rabbit IgG.
RESULTS
Constructing acircular chromosome vectorin human cells
To construct a chromosome vector that contained the
elements essential for both chromosome maintenance
and gene expression, a 50-kb alphoid DNA fragment
and a gene expression cassette cloned into bacterial artiﬁ-
cial chromosomes (alphoid-BAC, Lox-BAC; Figure 1a)
were co-transfected into HT1080 cells, transfectants were
selected with G418 and analyzed by FISH. In vivo multi-
merization of the alphoid-BAC and Lox-BAC within the
cells generated circular artiﬁcial chromosomes that har-
bored expression cassettes (Figure 1a). The expression cas-
sette consisted of a CAG promoter-drive neomycin
resistance gene (neo) with mutant loxP, lox71 and
human beta-globin 50HS5 and 30HS1 sites, which possess
chromatin boundary functions (17). The expression cas-
sette was utilized during drug selection for the construc-
tion of the artiﬁcial chromosome and for gene insertion.
While the number of expression cassettes in chromosome
vectors varied, we used one of the vectors (25-4) in
HT1080 cells (HT/25-4) that contained four gene expres-
sion cassettes for the remainder of the studies (Figure 1b).
Transferand availability of chromosomevectors into
vertebrate cells
To utilize the chromosome vector as a tool in several stu-
dies, it must be transferable and be retained stably within
the recipient cells. The useful method of transfer is
MMCT, in which 25-4 was transferred via microcells gen-
erated from the A9/HT hybrid cell lines harboring 25-4
to the target cells. The 25-4 vector was successfully
Figure 1. Construction and conﬁguration of chromosome vector 25-4. (a) The conﬁguration of precursor BACs and the composition of 25-4.
Alphoid-BAC contains 50kb of alphoid DNA and Lox-BAC contains the CAG/lox71/neo cassette with insulator elements (50HS5 and 30HS1).
The 25-4 is composed of alphoid DNA and four CAG/lox71/neo cassettes derived from Lox-BAC. (b) Southern analyses of 25-4. Genomic DNA of
HT1080 cells containing 25-4 was digested with I-SceI, StuI or SacI, and hybridized with BAC vector sequences or neomycin resistant gene sequences
(neo), respectively. I-SceI divided 25-4 into four fragments (800, 700, 300 and 200kb) (gray), StuI cut 25-4 into precursor 57-kb fragments derived
from alphoid-BACs (white) and 19-kb fragments derived from Lox-BACs (black) and SacI presented 9.5kb of expression cassettes (black).
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HeLa, NIH/3T3, pig (PK15), Indian Muntjac, rat
(IAR20), quail (QNR/K2), chicken (DT40), Xenopus
(A6), zebraﬁsh (AB.9) and mouse ES cells (TT2F), with
a chromosome loss rate of less than 0.5% per generation
(Figure 2). These results indicated that chromosomal fea-
tures and functions, including centromeres and replication
origins, in 25-4 were maintained in several vertebrate cell
lines and that 25-4 could be used as tool for stable gene
expression.
Regulation of promoter-dependent geneexpression from
achromosomevector
To investigate the ability of the 25-4 vector gene insertion
and expression system, we inserted an enhanced green ﬂu-
orescent protein (EGFP) gene driven by several diﬀerent
promoters (CMV, SV, EF1 and cyclin A) by Cre-lox
recombination of the lox66 site at the promoterless
cassette and lox71 site in the gene expression cassette of
25-4 in HT1080 cells (Figure 3a). The major event in
puromycin-resistant cell lines was insertion of the EGFP
gene in one expression cassette in four sites of 25-4. EGFP
expression was evaluated by ﬂuorescence intensity
(Figure 3b). The relative level of ﬂuorescence of
CMV-EGFP was greater than that of EF1-EGFP or
SV-EGFP, and two orders of magnitude greater than
that of cyclin A-EGFP. The expression of EGFP was
homogeneous in >90% of cells in each line, indicating
little variation in gene expression between cells within a
clonal HT/25-4 cell line (Figure 3b). This promoter-
dependent expression of EGFP from the 25-4 vector was
also observed in NIH/3T3 and CHO cells.
Construction of amini-genelocus
In order to develop a system for de novo construction of
genes within the context of their native chromatin archi-
tecture under cellular conditions, naked genomic DNA
was inserted into the gene expression cassette on the chro-
mosome vector. The genomic DNA cloned into the BAC
had been modiﬁed by addition of the lox/puromycin resis-
tance (puro) cassette in place of the loxP by Red/ET
recombination in E. coli. Subsequently, puriﬁed BAC
DNA was inserted into the gene expression cassette of
25-4 in cells by co-transfection with a Cre expression plas-
mid (Figure 4a). The human STAT3 gene, composed of
up-stream sequences, 24 exons and downstream
sequences, was used as a representative genomic sequence.
STAT3 is a signal transducer and transcriptional activa-
tor, and is essential for maintenance of undiﬀerentiated
mouse ES cells (18) (Figure 4b). More than 80% of trans-
formants contained one copy of the intact human STAT3
gene at the correct position by Cre-lox recombination
(Figure 4c). In ES cells, human STAT3 was actively
expressed from the 25-4 vector and the complete length
of the human STAT3 transcript was detected in 3 of 3 cell
lines derived from BAC 2047G9 and in 10 of 11 cell
lines from BAC 1781E2at the same level as native
human STAT3 expression in HT1080 (Figure 4d).
Figure 2. Stable retention of 25-4 vector in vertebrate cell lines. The vertebrate cell lines carrying 25-4 were established by MMCT. Transferred 25-4
was conﬁrmed by FISH using metaphase cells: CHO, mouse ES (TT2F), pig (PK15), chicken B cells (DT40), Xenopus (A6) and zebraﬁsh (AB.9).
Green signals show alphoid DNA and red signals show BAC vector. Arrowheads show 25-4 vector.
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cated that almost all cells in the cell lines expressed human
STAT3 (Figure 4e), and transcription was maintained in
mouse ES cells for 100 days in culture without noticeable
silencing (Figure 4f). These results indicated that following
insertion of naked DNA into chromosome vector in
mouse ES cells in which the endogenous Stat3 was
active, expression-permissive chromosomal architecture
was constructed around the transfected human STAT3
gene.
Epigenetic maintenance and changes in genearchitecture in
the STAT3locus
In order to examine the property of the de novo con-
structed gene locus, human STAT3 DNA was inserted
into the 25-4 vector in CHO cells (CHO/STAT), which
are often used for protein production. While the sequence
of the Chinese hamster endogenous STAT3 gene was
unknown, RT–PCR using primers for exons 2 and 9 of
human STAT3, which are highly conserved between
humans and mice, produced 0.9-kb fragments from both
human and CHO cells (Figure 5a, b). Restriction analysis
with BglII, a human STAT3-speciﬁc restriction site,
indicated that human STAT3 was not expressed in any
CHO/STAT cell line, despite active expression of hamster
STAT3 (Figure 5a, b).
To investigate reasons for the diﬀerences in transcrip-
tional status of human STAT3 in ES cells (expression) and
CHO cells (repression), we analyzed the methylation
status of human STAT3 in mouse ES (ES/STAT) and
CHO (CHO/STAT) cells by restriction enzyme digestion
(Figure 5c). A1234-bp sequence of 50-upstream DNA and
1283bp of 30-untranslational region in exon 24 of human
STAT3 were distinguishable from those of mouse ES and
CHO cells (Figure 5a). The methylation status of human
STAT3 was determined by the digestion pattern of AciI,
which is sensitive to CpG methylation. The digestion pat-
tern indicated that both the 50 and 30 regions of human
STAT3 were completely methylated under the natural and
expression-active conditions of the HT1080 cells. The
majority of the human STAT3 genes in mouse ES cells
(ES/STAT) were fully methylated and some were partially
methylated, whereas human STAT3 genes in CHO cells
(CHO/STAT) were unmethylated as compared to the
native region in HT1080 cells (Figure 5c). These results
indicated that methylation of the 50 region of human
STAT3 was important for attaining the epigenetic status
necessary for active expression.
Figure 3. Gene expression from the 25-4 vector. (a) Gene insertion into the 25-4 vector. The EGFP gene was inserted into 25-4 vector using Cre-lox
recombination in HT1080 cells. Successful recombinants were selected by puromycin resistance (puro). (b) EGFP expression levels in 25-4.
Fluorescence of CMV-, SV-, EF1- or cyclin A-driven expression of EGFP in HT1080 cells.
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activated in diﬀerent cellular conditions, human STAT3
genes within the context of repressed chromatin in CHO
cells were transferred from CHO cells to mouse ES or
NIH/3T3 cells using MMCT. The expression of human
STAT3 in each mouse recipient cell line was detected
by RT–PCR (Figure 5d) and the methylation status of
the 50 and 30 regions was analyzed by AciI digestion
(Figure 5c). RT–PCR indicated that human STAT3 trans-
ferred from CHO to ES cells [ES/STAT(CHO)] was acti-
vated in all of the independent cell lines, while human
STAT3 transferred from CHO to NIH/3T3 cells [NIH/
STAT(CHO)] was activated to varying degrees or
remained repressed (Figure 5d). The DNA methylation
Figure 4. De novo construction of a human STAT3 mini-locus on 25-4 vector. (a) Strategy for modifying and inserting genomic DNA from BAC into
chromosome vector. TT2F/25-4 cells that contained the human STAT3 genomic gene were selected with puromycin and drug-resistant cell lines were
conﬁrmed by PCR with CAG promoter and puro sequences, and by FISH using STAT3 and BAC sequences as probes. (b) The genomic composition
of human STAT3 genes. Clone 2047G9 contains 139-kb of the upstream and 5-kb of the downstream regions of human STAT3. Clone 1781E2
contains 15-kb of upstream and 85-kb of downstream regions of human STAT3. The numbers in the boxes delineate exons. (c) FISH analysis of
mouse ES cells containing human STAT3 mini-locus. Metaphase chromosomes were hybridized with human STAT3 cDNA (green) and BAC vector
(red) sequences. Arrowhead shows 25-4 containing human STAT3; arrows show endogenous mouse Stat3.( d) Expression of human STAT3 from
25-4. The 2.2-kb fragments from human STAT3 transcripts were detected by RT–PCR in all ES cell lines that contained human STAT3.( e)
Detection of human STAT3 products in TT2F/25-4 containing human STAT3. The STAT3 products were detected by anti-human STAT3 antibody
in methanol-ﬁxed cells. Green signals show human STAT3 products. (f) Expression of human STAT3 after long-term culturing. The TT2F/25-4 cells
containing human STAT3 were cultured for 60 and 100 days and subsequently analyzed by RT–PCR. Human STAT3 transcripts were detected as
before culturing.
e44 Nucleic Acids Research,2009, Vol. 37,No. 6 PAGE6 OF 9Figure 5. Transfer of human STAT3 chromatin architecture. (a) Comparison of human, mouse and Chinese hamster STAT3 genes. Gray boxes show
conserved regions, broken boxes show unknown regions. The numbers signify exons. AciI restriction enzyme sites in upstream of the promoter (50)
and in the last half of exon 24 (30) are shown by open arrowheads. The BglII site is shown by a closed arrowhead. (b) RT–PCR of human STAT3
from CHO/STAT. STAT3 transcripts (about 1kb) were detected in HT1080, CHO and four CHO lines that contained human STAT3 (CHO/STAT)
by RT–PCR using primers corresponding to exons 2 and 9. Digestion of the transcripts with BglII produced 0.5- and 0.4-kb fragments of human
STAT3 transcripts from HT1080 and nondigested 1.0-kb fragments from endogenous STAT3 in CHO cells and all CHO/STAT cell lines. (c) DNA
methylation analysis in the 50 and 30 regions of human STAT3. Genomic DNA from HT1080, ES/STAT, CHO/STAT, two ES/STAT(CHO) and
four NIH/STAT(CHO) cell lines was digested with MscI and DraI, or AﬂII and MscI, with (+) or without ( ) AciI, and subsequently hybridized
with 50 or 30 probes. The 1.2-kb fragments from digestion with AciI indicate a completely methylated state. (d) Detection of human STAT3
transcripts. Human STAT3 transcripts were detected in HT1080, mouse ES, CHO, NIH/3T3, ﬁve ES/STAT(CHO) and six NIH/STAT(CHO)
cell lines by RT–PCR using human-speciﬁc primers corresponding to exons 2 and 24. A 2.2-kb fragment of the human STAT3 transcript was
detected in all ﬁve ES/STAT(CHO) cell lines, while transcript detection varied in the six NIH/STAT(CHO) cell lines.
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cells was changed to match that of the de novo constructed
STAT3 loci in ES cells, while STAT3 transferred from
CHO to NIH/3T3 cells showed increased methylation in
expression-active cell lines or remained unmethylated in
expression-negative cell lines (Figure 5c). The correlation
between gene expression and DNA methylation was indi-
cated in the 50 region of STAT3, where full methylation
was required for gene expression.
These results demonstrate that the human STAT3
gene adopted diﬀerent chromatin architectures in cell
lines derived from diﬀerent tissues or species, and once
established, the chromatin architecture was maintained
or changed according to the cellular conditions by
mechanisms involving DNA methylation.
DISCUSSION
We created functionally open chromatin sites in HAC
vectors that contained insulators (19), which protect
gene expression from gene silencing, and a CAG promo-
ter, which activates chromatin for gene expression
(Figure 1). Recent insights suggested that insulators per-
form dual functions as enhancer blockers and as barriers
against the spread of heterochromatin. Here, we showed
that the human globin HS sequences could functionally
divide the domains of HAC by providing a barrier struc-
ture or could inﬂuence the balance of activation and
silencing functions by participating in transcription-
speciﬁc chromatin architectures. The expression of
EGFP from the HAC vector showed that these chromatin
sites regulated gene expression according to the promoter
rather than by simple ‘all or none’ activation (Figure 3).
In the presence of the boundary elements, the inserted
gene responded appropriately to the ambient cellular con-
ditions and this may be related to chromatin structural
and epigenetic (in particular, DNA methylation) status
that is generated in the diﬀerent cell types.
The de novo-constructed human STAT3 chromatin in
mouse ES cell lines was actively expressed and the level
of DNA methylation in the 50 and 30 regions of the gene
was as high as that in native STAT3 genes. Therefore,
genomic DNA inserted in an HAC vector can be packaged
into chromatin with a natural DNA methylation pattern.
Most human genes regulated by native promoters are
thought to function in other mammalian cells, including
murine cells. However, human STAT3 on chromosome
vector was repressed in all CHO cells, while the endogen-
ous CHO STAT3 was actively expressed (Figure 5b).
Human STAT3 repression in CHO cells was probably
a product of the chromatin architecture, including the
DNA methylation pattern, rather than a lack of recogni-
tion of human sequences by the CHO transcription
machinery, because methylation in the 50 and 30 regions
of human STAT3 in CHO cells was lower than in
human and mouse cells. In many genes, a low level
of DNA methylation in the promoter and up-stream
region is requisite for active expression, however, the
highly methylated status that correlates with expression-
active architecture might not have been appropriately
positioned in the 50 region of the human STAT3 gene in
CHO cells.
In this study, the transcriptionally inactive chromatin
architecture of the human STAT3 gene constructed in
CHO cells was remodeled into transcriptionally active
chromatin in ES cells by a mechanism involving DNA
methylation. The methylation pattern underwent inter-
and intra-cell line changes when human STAT3 architec-
ture was transferred from CHO cells into mouse NIH/3T3
cells. In some cases, the architectural status was interme-
diate between ES and CHO types, while in others the
status was unchanged from CHO type (Figure 5c). These
results indicated that the cells have the potential to remo-
del or maintain chromatin structure through DNA methy-
lation. Each epigenetic state was established by the
balance of the two potentials. ES cells demonstrated a
powerful force for remodeling as opposed to maintaining
the human STAT3 chromatin status, corresponding
with previous reports of their ability to reprogram
somatic nuclei (20). The HAC vector technology described
herein allows us to conduct experiments involving the
establishment, modiﬁcation and maintenance of chroma-
tin epigenetics in various cell types. These types of tech-
nologies could be utilized in basic biological research as
well as applied to stem cell science and regeneration
medicine.
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